Remedent Announces Filing of Form 12b-25, Notification of Late Filing and to Host a Conference Call on Wednesday, November 30...
16 November 2011 - 2:00AM
Marketwired
Remedent, Inc. ("Remedent" or the "Company") (OTCBB: REMI), an
international company specializing in research, development, and
the manufacturing of oral care and cosmetic products, announced
today that it filed a Form 12b-25, Notification of Late Filing,
with the Securities and Exchange Commission with regard to its form
10-Q report for the quarter ended September 30, 2011. This allows
the Company an additional 5 business days to file the form 10-Q
which otherwise would be due on November 14, 2011. The Company
expects to file the 10-Q on or before November 21, 2011. In
addition, the Company will host a conference call on Wednesday,
November 30 at 11 AM Eastern Standard Time to discuss the operating
results for the quarter ended September 30, 2011. Details of the
conference call are outlined below.
Conference Call Information
Date: Wednesday, November 30, 2011 Time: 11:00 AM Eastern
Standard Time (8:00 AM Pacific Standard Time) Dial in number:
888-437-9315 Pass code: 1535480
A telephone replay of the call will be available until Tuesday,
December 13, 2011 Toll Free Replay Number: 888-203-1112 Replay
Password: 1535480
About Remedent
Remedent, Inc. specializes in the research, development and
manufacturing and the marketing of oral care and cosmetic dental
products. The Company serves the professional dental industry with
breakthrough technology for dental veneers. These products are
supported by a line of professional veneer whitening and tooth
sensitivity solutions. Headquartered in Belgium, Remedent
distributes its products to more than 55 countries in the
worldwide. For more information, go to www.remedent.com.
Forward-Looking Statements
Statements in this press release that are "forward-looking
statements" are based on current expectations and assumptions that
are subject to risks and uncertainties. Such forward-looking
statements involve known and unknown risks, uncertainties and other
unknown factors that could cause Remedent's actual operating
results to be materially different from any historical results or
from any future results expressed or implied by such
forward-looking statements. In addition to statements that
explicitly describe these risks and uncertainties, readers are
urged to consider statements that contain terms such as "believes,"
"belief," "expects," "expect," "intends," "intend," "anticipate,"
"anticipates," "plans," "plan," "projects," "project," to be
uncertain and forward-looking. Actual results could differ
materially because of factors such as Remedent's ability to achieve
the synergies and value creation contemplated by the proposed
transaction. For further information regarding risks and
uncertainties associated with Remedent's business, please refer to
the risk factors described in Remedent's filings with the
Securities and Exchange Commission, including, but not limited to,
its annual report on Form 10-K and quarterly reports on Form 10-Q.
We undertake no duty to revise or update any forward-looking
statements to reflect events or circumstances after the date of
this press release.
CONTACT: Stephen Ross 310 922 5685 docktor99@aol.com
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024